<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v6i3.3757</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Th17 Cells and Tregs in HTLV-1 Infection</title><url>https://artdesignp.com/journal/JCNR/6/3/10.26689/jcnr.v6i3.3757</url><author>Nafiseh Saghafi,ElhamAbdollahi,MofradMalihe Hasanzadeh</author><pub-date pub-type="publication-year"><year>2022</year></pub-date><volume>6</volume><issue>3</issue><history><date date-type="pub"><published-time>2022-05-19</published-time></date></history><abstract>HTLV-1 (human T-lymphotropic virus type 1) causes chronic infection of human T lymphocytes. HTLV-1 infection is known to be related to multiple diseases, including neoplastic growth of HTLV-1-infected T cells (ATL) and neoplastic inflammatory conditions, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Sjögren’s syndrome with arthritis, polymyositis uveitis, and bronchoalveolitis. Regulatory T cells (Tregs) regulate inflammatory cells, such as&amp;nbsp;Th17 cells. The purpose of this study was to evaluate Tregs and Th17 cells, as well as the expression of related transcription factors (ROR-?t and FOXP3) and cytokines (IL-10, TGF-?, IL-6, and IL-17A) in HTLV-1 infection. </abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Boostani R, Lotfinejad N, Zemorshidi F, et al., 2021, Planning and Management to Control and Eliminate HTLV-1 Infection in Iran. Iranian Journal of Basic Medical Sciences, 24(3): 264-266.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Araya N, Sato T, Yagishita N, et al., 2011, Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease. Viruses, 3(9): 1532-1548.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Birmann BM, Breen EC, Stuver S, et al., 2009, Population Differences in Immune Marker Profiles Associated with Human T?Lymphotropic Virus Type I Infection in Japan and Jamaica. International Journal of Cancer, 124(3): 614-621.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Tarokhian H, Rahimi H, Mosavat A, et al., 2018, HTLV-1-Host Interactions on the Development of Adult T Cell Leukemia/Lymphoma: Virus and Host Gene Expressions. BMC Cancer, 18(1): 1-12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Carpentier A, Barez P-Y, Hamaidia M, et al., 2015, Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence. Viruses, 7(7): 3603-3624.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Nagate Y, Ezoe S, Fujita J, et al., 2021, Ectonucleotidase CD39 is Highly Expressed on ATLL Cells and Is Responsible for Their Immunosuppressive Function. Leukemia, 35(1): 107-118.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Higuchi Y, Yasunaga J-i, Mitagami Y, et al., 2020, HTLV-1 Induces T Cell Malignancy and Inflammation by Viral Antisense Factor-Mediated Modulation of the Cytokine Signaling. Proceedings of the National Academy of Sciences, 117(24): 13740-13749.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Koyanagi Y, Itoyama Y, Nakamura N, et al., 1993, In Vivo Infection of Human T-Cell Leukemia Virus Type I in Non-T Cells. Virology, 196(1): 25-33.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Mohammadi S, Abdollahi E, Nezamnia M, et al., 2020, Adoptive Transfer of Tregs: A Novel Strategy for Cell-Based Immunotherapy in Spontaneous Abortion: Lessons from Experimental Models. International Immunopharmacology, 90: 107195.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Lippi G, Lavie CJ, Sanchis-Gomar F, 2020, Cardiac Troponin I in Patients with Coronavirus Disease 2019 (COVID-19): Evidence from a Meta-Analysis. Progress in Cardiovascular Diseases, 63(3): 390-391.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Bhatla A, Mayer MM, Adusumalli S, et al., 2020, COVID-19 and Cardiac Arrhythmias. Heart Rhythm, 17(9): 1439-1444.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Christoffersson G, von Herrath M, 2019, Regulatory Immune Mechanisms Beyond Regulatory T Cells. Trends in Immunology, 40(6): 482-491.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Romano M, Fanelli G, Albany CJ, et al., 2019, Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity. Frontiers in Immunology, 10: 43.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Bouwman W, Verhaegh W, Holtzer L, et al., 2020, Measurement of Cellular Immune Response to Viral Infection and Vaccination. Frontiers in Immunology, 11: 2719.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Jin Y, Wi HJ, Choi M-H, et al., 2014, Regulation of Anti-Inflammatory Cytokines IL-10 and TGF-? in Mouse Dendritic Cells Through Treatment with Clonorchis Sinensis Crude Antigen. Experimental &amp; Molecular Medicine, 46(1): e74.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><p>Sanjabi S, Zenewicz LA, Kamanaka M, et al., 2009, Anti-Inflammatory and Pro-Inflammatory Roles of TGF-?, IL-10, and IL-22 in Immunity and Autoimmunity. Current Opinion in Pharmacology, 9(4): 447-453.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><p>Veldhoen M, Hocking RJ, Atkins CJ, et al., 2006, TGF? in the Context of An Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells. Immunity, 24(2): 179-189.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><p>Konkel JE, Zhang D, Zanvit P, et al., 2017, Transforming Growth Factor-? Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses. Immunity, 46(4): 660-674.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><p>Fujimoto Y, Kuramoto N, Yoneyama M, et al., 2020, Interleukin-19 as An Immunoregulatory Cytokine. Current Molecular Pharmacology, 14(2): 191-199.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><p>Abdollahi E, Tavasolian F, Ghasemi N, et al., 2015, Association Between Lower Frequency of R381Q Variant (Rs11209026) in IL-23 Receptor Gene and Increased Risk of Recurrent Spontaneous Abortion (RSA). Journal of Immunotoxicology, 12(4): 317-321.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B21" content-type="article"><label>21</label><element-citation publication-type="journal"><p>Martinez NE, Sato F, Kawai E, et al., 2012, Regulatory T Cells and Th17 Cells in Viral Infections: Implications for Multiple Sclerosis and Myocarditis. Future Virology, 7(6): 593-608.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B22" content-type="article"><label>22</label><element-citation publication-type="journal"><p>Castro G, Liu X, Ngo K, et al., 2017, ROR?t and ROR? Signature Genes in Human Th17 Cells. PloS ONE, 12(8): E0181868.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B23" content-type="article"><label>23</label><element-citation publication-type="journal"><p>Neco HV, Teixeira VG, Trindade AC, et al., 2017, IL17A Polymorphism Is Not Associated with Human T-Lymphotropic Virus 1-Associated Myelopathy/Tropical Spastic Paraparesis. Viral Immunology, 30(4): 298-301.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B24" content-type="article"><label>24</label><element-citation publication-type="journal"><p>Kany S, Vollrath JT, Relja B, 2019, Cytokines in Inflammatory Disease. International Journal of Molecular Sciences, 20(23): 6008.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B25" content-type="article"><label>25</label><element-citation publication-type="journal"><p>Hamano R, Wu X, Wang Y, et al., 2015, Characterization of MT-2 Cells as A Human Regulatory T Cell-Like Cell Line. Cellular &amp; Molecular Immunology, 12(6): 780-782.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B26" content-type="article"><label>26</label><element-citation publication-type="journal"><p>Meissner ME, Mendonça LM, Zhang W, et al., 2017, Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed Through Characterization of A Chronically Infected Cell Line. Journal of Virology, 91(16): e00369-17.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B27" content-type="article"><label>27</label><element-citation publication-type="journal"><p>Satou Y, Yasunaga J-i, Zhao T, et al., 2011, HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo. PloS Pathog, 7(2): e1001274.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B28" content-type="article"><label>28</label><element-citation publication-type="journal"><p>Kchour G, Rezaee SR, Farid R, et al., 2013, The Combination of Arsenic, Interferon-Alpha, and Zidovudine Restores An “Immunocompetent-Like” Cytokine Expression Profile in Patients with Adult T-Cell Leukemia Lymphoma. Retrovirology, 10(1): 1-12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B29" content-type="article"><label>29</label><element-citation publication-type="journal"><p>Swaims AY, Khani F, Zhang Y, et al., 2010, Immune Activation Induces Immortalization of HTLV-1 LTR-Tax Transgenic CD4+ T Cells. Blood, 116(16): 2994-3003.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B30" content-type="article"><label>30</label><element-citation publication-type="journal"><p>Champs APS, de Azeredo Passos VM, Carvalho G, et al., 2019, Cognitive Impairment in HTLV-1-Associated Myelopathy, Proviral Load and Inflammatory Markers. International Journal of Infectious Diseases, 84: 121-126.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B31" content-type="article"><label>31</label><element-citation publication-type="journal"><p>Quaresma JA, Yoshikawa GT, Koyama RV, et al., 2016, HTLV-1, Immune Response and Autoimmunity. Viruses, 8(1): 5.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B32" content-type="article"><label>32</label><element-citation publication-type="journal"><p>Eggenhuizen PJ, Ng BH, Ooi JD, 2020, Treg Enhancing Therapies to Treat Autoimmune Diseases. International Journal of Molecular Sciences, 21(19): 7015.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B33" content-type="article"><label>33</label><element-citation publication-type="journal"><p>Mohammadi S, Abdollahi E, Nezamnia M, et al., 2021, Adoptive Transfer of Tregs: A Novel Strategy for Cell-Based Immunotherapy in Spontaneous Abortion: Lessons from Experimental Models. International Immunopharmacology, 90: 107195.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B34" content-type="article"><label>34</label><element-citation publication-type="journal"><p>Guo K, Zhang X, 2021, Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. Journal of Immunology Research, 2021: 6693542.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B35" content-type="article"><label>35</label><element-citation publication-type="journal"><p>Abdollahi E, Tavasolian F, Momtazi-Borojeni AA, et al., 2016, Protective Role of R381Q (rs11209026) Polymorphism in IL-23R Gene in Immune-Mediated Diseases: A Comprehensive Review. Journal of Immunotoxicology, 13(3): 286-300.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B36" content-type="article"><label>36</label><element-citation publication-type="journal"><p>Yamano Y, Araya N, Sato T, et al., 2009, Abnormally High Levels of Virus-Infected IFN-?+ CCR4+ CD4+ CD25+ T Cells in A Retrovirus-Associated Neuroinflammatory Disorder. PloS ONE, 4(8): E6517.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B37" content-type="article"><label>37</label><element-citation publication-type="journal"><p>Oh U, Grant C, Griffith C, et al., 2006, Reduced Foxp3 Protein Expression Is Associated with Inflammatory Disease During Human T Lymphotropic Virus Type 1 Infection. The Journal of Infectious Diseases, 193(11): 1557-1566.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B38" content-type="article"><label>38</label><element-citation publication-type="journal"><p>Satou Y, Matsuoka M, 2010, HTLV-1 and the Host Immune System: How the Virus Disrupts Immune Regulation, Leading to HTLV-1 Associated Diseases. Journal of Clinical and Experimental Hematopathology, 50(1): 1-8.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B39" content-type="article"><label>39</label><element-citation publication-type="journal"><p>Toulza F, Heaps A, Tanaka Y, et al., 2008, High Frequency of CD4+ FoxP3+ Cells in HTLV-1 Infection: Inverse Correlation with HTLV-1-Specific CTL Response. Blood. The Journal of the American Society of Hematology, 111(10): 5047-5053.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B40" content-type="article"><label>40</label><element-citation publication-type="journal"><p>Brito?Melo G, Peruhype?Magalhaes V, Teixeira?Carvalho A, et al., 2007, IL?10 Produced by CD4+ and CD8+ T Cells Emerge as A Putative Immunoregulatory Mechanism to Counterbalance the Monocyte?Derived TNF?? and Guarantee Asymptomatic Clinical Status During Chronic HTLV?I Infection. Clinical &amp; Experimental Immunology, 147(1): 35-44.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B41" content-type="article"><label>41</label><element-citation publication-type="journal"><p>de Sa KSG, Santana BB, de Souza Ferreira TC, et al., 2016, IL28B Gene Polymorphisms and Th1/Th2 Cytokine Levels Might Be Associated with HTLV-Associated Arthropathy. Cytokine, 77: 79-87.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B42" content-type="article"><label>42</label><element-citation publication-type="journal"><p>Sasada A, Takaori-Kondo A, Shirakawa K, et al., 2005, APOBEC3G Targets Human T-Cell Leukemia Virus Type 1. Retrovirology, 2(1): 1-10.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B43" content-type="article"><label>43</label><element-citation publication-type="journal"><p>Best I, Lopez G, Verdonck K, et al., 2009, IFN?? Production in Response to Tax 161–233, and Frequency of CD4+ Foxp3+ and Lin? HLA?DRhigh CD123+ Cells, Discriminate HAM/TSP Patients from Asymptomatic HTLV?1?Carriers in A Peruvian Population. Immunology, 128(1pt2): e777-e786.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B44" content-type="article"><label>44</label><element-citation publication-type="journal"><p>Araujo AQ, Leite ACC, Lima MAS, et al., 2009, HTLV-1 and Neurological Conditions: When to Suspect and When to Order A Diagnostic Test for HTLV-1 Infection?. Arq Neuropsiquiatr, 67(1): 132-138.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B45" content-type="article"><label>45</label><element-citation publication-type="journal"><p>Castro-Costa CMd, Araujo AdQC, Camara CC, et al., 2009, Pain in Tropical Spastic Paraparesis/HTLV-I Associated Myelopathy Patients. Arq Neuropsiquiatr, 67(3B): 866-870.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
